These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24161159)

  • 1. Prescribing patterns of duloxetine in France: a prescription assessment study in real-world conditions.
    Augendre-Ferrante B; Picard H; Evans D; Arkoub H; Pamulapati S; Perrot S; Valensi P; Rouillon F
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):1-7. PubMed ID: 24161159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosing patterns for duloxetine and predictors of high-dose prescriptions in patients with major depressive disorder: analysis from a United States third-party payer perspective.
    Liu X; Cui Z; Niu L; Faries DE; Ball T; Johnstone B
    Clin Ther; 2011 Nov; 33(11):1726-38. PubMed ID: 22019345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
    Wu WY; Wang G; Ball SG; Desaiah D; Ang QQ
    Chin Med J (Engl); 2011 Oct; 124(20):3260-8. PubMed ID: 22088518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
    Tomita T; Yasui-Furukori N; Kaneko S
    Clin Neuropharmacol; 2013; 36(5):175-6. PubMed ID: 24045610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study.
    Shi L; Liu J; Campbell C; Zhao Y
    Curr Med Res Opin; 2010 Dec; 26(12):2715-21. PubMed ID: 20973616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
    Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.
    Fava M; Wiltse C; Walker D; Brecht S; Chen A; Perahia D
    J Affect Disord; 2009 Mar; 113(3):263-71. PubMed ID: 18625521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.
    Cui Z; Faries DE; Zhao Y; Novick D; Liu X
    J Med Econ; 2011; 14(5):662-72. PubMed ID: 21892857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
    Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS
    Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
    Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the acute and continuation treatment of major depressive disorder.
    Bochsler L; Olver JS; Norman TR
    Expert Rev Neurother; 2011 Nov; 11(11):1525-39. PubMed ID: 22014130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
    Gahimer J; Wernicke J; Yalcin I; Ossanna MJ; Wulster-Radcliffe M; Viktrup L
    Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC
    Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.